Literature DB >> 179476

Vincristine toxicity unrelated to dose.

M J O'Callaghan, H Ekert.   

Abstract

Four children with vincristine toxicity unrelated to dose are described. Fever, haematological toxicity, and abdominal distension occurred 2-7 days after vincristine was given. Convulsions occurred 6-8 days after vincristine in all 4. Inappropriate secretion of antidiuretic hormone was thought to have occurred in 3 patients. 2 patients died during the acute toxicity phase. Necropsy findings did not show neuronal changes which could be directly ascribed to vincristine.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 179476      PMCID: PMC1545956          DOI: 10.1136/adc.51.4.289

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  14 in total

Review 1.  Neurotoxicity of commonly used antineoplastic agents (second of two parts).

Authors:  H D Weiss; M D Walker; P H Wiernik
Journal:  N Engl J Med       Date:  1974-07-18       Impact factor: 91.245

Review 2.  Vincristine neurotoxicity.

Authors:  S Rosenthal; S Kaufman
Journal:  Ann Intern Med       Date:  1974-06       Impact factor: 25.391

3.  Letter: Coma and convulsions associated with vincristine therapy.

Authors:  J Martin; D Mainwaring
Journal:  Br Med J       Date:  1973-12-29

4.  Vincristine neurotoxicity and abnormal secretion of antidiuretic hormone.

Authors:  G L Robertson; N Bhoopalam; L J Zelkowitz
Journal:  Arch Intern Med       Date:  1973-11

5.  Syndrome of inappropriate secretion of antidiuretic hormone produced by vincristine toxicity (with bioassay of ADH level).

Authors:  R M Suskind; S W Brusilow; J Zehr
Journal:  J Pediatr       Date:  1972-07       Impact factor: 4.406

Review 6.  Neurological complications of systemic cancer.

Authors:  J B Posner
Journal:  Med Clin North Am       Date:  1971-05       Impact factor: 5.456

7.  Seizures associated with vincristine sulfate therapy.

Authors:  F L Johnson; I D Bernstein; J R Hartmann; R L Chard
Journal:  J Pediatr       Date:  1973-04       Impact factor: 4.406

8.  Vincristine neurotoxicity with hyponatremia.

Authors:  L M Slater; R A Wainer; A A Serpick
Journal:  Cancer       Date:  1969-01       Impact factor: 6.860

9.  Coma associated with vincristine therapy.

Authors:  J A Whittaker; D H Parry; C Bunch; D J Weatherall
Journal:  Br Med J       Date:  1973-11-10

10.  Syndrome of recurrent increased secretion of antidiuretic hormone following multiple doses of vincristine.

Authors:  M J Stuart; C Cuaso; M Miller; F A Oski
Journal:  Blood       Date:  1975-03       Impact factor: 22.113

View more
  2 in total

Review 1.  The double-edged sword: Neurotoxicity of chemotherapy.

Authors:  Rajiv S Magge; Lisa M DeAngelis
Journal:  Blood Rev       Date:  2014-09-28       Impact factor: 8.250

2.  The pharmacokinetics of vincristine in man: reduced drug clearance associated with raised serum alkaline phosphatase and dose-limited elimination.

Authors:  H W Van den Berg; Z R Desai; R Wilson; G Kennedy; J M Bridges; R G Shanks
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.